Clinical Trial Update: A Study of Gastric Delay in Migraine Patients (3207-003) [Phase 1]

View source ↗

Summary

This entry notes the completion of a Phase 1 study evaluating gastric delay in patients with migraine (study 3207-003) sponsored by Merck Sharp & Dohme.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine Disorders

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Migraine Disorders | Phase 1 | Status: COMPLETED